Jutras-Aswad, Didier
$4,986,431.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- Research in Priority Areas
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- April 1, 2022 – March 31, 2026
- Reference
- cihr-irsc:236-2022-2023-Q1-00917
Published purpose
The specific objective of this funding opportunity are to: - provide the base/infrastructure funding to the CRISM Phase II Regional Nodes that will allow research teams to organize and collaborate to address critical research in the area of substance use, and to allow them to: o identify and develop clinical and community-based prevention or treatment interventions and guidelines, including harm reduction, for substance use o provide evidence to decision makers, providers and stakeholders, to support the enhancement of prevention or treatment services, as well as policy development, regarding substance use o engage Indigenous Peoples in Canada in research and KT efforts in a manner respecting the rights of Indigenous Peoples and Indigenous self-determination and self-governance, such as following the First Nations Principles of OCAP® (i.e., Ownership, Control, Access and Possession), or employing a distinctions-based approach o support the improvement in the quality of care and quality of life for Canadians with substance use disorder o involve individuals with lived and living experience throughout the research process - conduct a Controlled Trial for management of methamphetamine use disorder aligned with the NIDA CTN
Community tags
Tags are applied by readers, not by this site. One tag per person per record.